BMB Reports

Korean Society for Biochemistry and Molecular Biology (생화학분자생물학회)
권호 표지
DOI QR코드

DOI QR Code

Identification of a lead small-molecule inhibitor of anthrax lethal toxin by using fluorescence-based high-throughput screening

  • Wei, Dong (Beijing Center for Disease Control and Prevention) ;
  • Bu, Zhaoyun (The Peopl's Hospital of Rizhao City) ;
  • Yu, Ailian (Department of Aetiology and Institute of Aetiology, Taishan College of Medicine) ;
  • Li, Feng (Beijing Center for Disease Control and Prevention)
  • Received : 2011.07.21
  • Accepted : 2011.09.09
  • Published : 2011.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Inhalational anthrax is caused by B. anthracis, a virulent sporeforming bacterium which secretes anthrax toxins consisting of protective antigen (PA), lethal factor (LF) and edema factor (EF). LF is a Zn-dependent metalloprotease and is the main determinant in the pathogenesis of anthrax. Here we report the identification of a lead small-molecule inhibitor of anthrax lethal factor by screening an available synthetic small-molecule inhibitor library using fluorescence-based high-throughput screening (HTS) approach. Seven small molecules were found to have inhibitory effect against LF activity, among which SM157 had the highest inhibitory activity. All theses small molecule inhibitors inhibited LF in a noncompetitive inhibition mode. SM157 and SM167 are from the same family, both having an identical group complex, which is predicted to insert into S1' pocket of LF. More potent small-molecule inhibitors could be developed by modifying SM157 based on this identical group complex.

Keywords

References

  1. Frazier, A. A., Franks, T. J. and Galvin, J. R. (2006) Inhalational anthrax. J. Thorac. Imaging 21, 252-258. https://doi.org/10.1097/01.rti.0000213570.71161.84
  2. Janeway, Jr., C. A. and Medzhitov. R. (2002) Innate immune recognition. Annu. Rev. Immunol. 20, 197-216. https://doi.org/10.1146/annurev.immunol.20.083001.084359
  3. Pannifer, A. D., Wong, T. Y., Schwarzenbacher, R., Renatus, M., Petosa, C., Bienkowska, J., Lacy, D. B., Collier, R., Park, S., Leppla, H., Hunna, P. and Liddington, R. C. (2001) Crystal structure of the anthrax lethal factor. Nature 414, 229-233. https://doi.org/10.1038/n35101998
  4. Hanna, P., Acosta, D. and Collier, R. J. (1993) On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. 90, 10198-10201. https://doi.org/10.1073/pnas.90.21.10198
  5. Tournier, J. N., Quesnel-Hellmann, A., Cleret, A. and Vidal, D. R. (2007) Contribution of toxins to the pathogenesis of inhalational anthrax. Cellular Microbiology 9, 555-565. https://doi.org/10.1111/j.1462-5822.2006.00866.x
  6. Boyden, E. D. and Dietrich, W. F. (2006) Nalp 1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nature Genetics 38, 240-244. https://doi.org/10.1038/ng1724
  7. Schepetkin, I. A., Khlebnikov, A. I., Kirpotina, L. N. and Quinn, M. T. (2006) Novel small-molecule inhibitors of anthrax lethal factor identified by high-throughput screening. J. Med. Chem. 49, 5232-5244. https://doi.org/10.1021/jm0605132
  8. Duesberya, N. S. and Vande Woudeb, G. F. (1999) Anthrax toxins. Cell. Mol. Life Sci. 55, 1599-1609. https://doi.org/10.1007/s000180050399
  9. Turk, B. E. (2008) Discovery and development of anthrax lethal factor metalloprotease inhibitor. Curr. Pharm. Biotechno. 9, 24-33. https://doi.org/10.2174/138920108783497604
  10. Peinado, J. R., Kacprzak, M. M., Leppla, S. H. and Lindberg, I. (2004) Cross-inhibition between furin and lethal factor inhibitors. Biochem. Bioph. Res. Co. 321, 601-605. https://doi.org/10.1016/j.bbrc.2004.07.012
  11. Huber, M., Vor Dem, E. U., Grunow, R. and Bessler, W. G. (2005) Generation of mouse polyclonal and human monoclonal antibodies against Bacillus anthracis toxin. Drugs Exp. Clin. Res. 31, 35-43.
  12. Mourez, M., Kane, R. S., Mogridge, J., Metallo, S., Deschatelets, P., Sellman, B. R., Whitesides, G. M. and Collier, R. J. (2001) Designing a polyvalent inhibitor of anthrax toxin. Nat. Biotechnol. 19, 958-961. https://doi.org/10.1038/nbt1001-958
  13. Duesbery, N. S., Webb, C. P., Leppla, S. H., Gordon, V. M., Klimpel, K. R., Copeland, T. D., Ahn, N. G., Oskarsson, M. K., Fukasawa, K., Paull, K. D. and Vande Woude, G. F. (1998) Proteolytic inactivation of MAP kinase kinase by anthrax lethal factor. Science 280, 734-737. https://doi.org/10.1126/science.280.5364.734
  14. Barrett, A. J., Rawlings, N. D. and Woessner, J. F. (2004) Introduction: metallopeptidases and their clans. in Handbook of proteolytic enzymes. Elsevier academic press, London, UK.
  15. Turk, B. E., Wong, T. Y., Schwarzenbacher, R., Jarrell, E. T., Leppla, S. H., Collier, R. J., Liddington, R. C. and Cantley, L. C. (2004) The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nat. Struct. Mol. Biol. 11, 60-66. https://doi.org/10.1038/nsmb708
  16. Panchal, R. G., Hermone, A. R., Nguyen, T. L., Wong, T.Y. Schmidt, J., Lane, D., McGrath, C., Turk, B. E., Burnett, J., Aman, M. J., Little, S., Sausville, E. A., Zaharevitz, D. W., Cantley, L. C., Liddington, R. C., Gussio, R. and Bavari, S. (2004) Identification of small molecule inhibitors of anthrax lethal factor. Nat. Struct. Mol. Biol. 11, 67-72. https://doi.org/10.1038/nsmb711
  17. Copeland, R. (2000) Enzymes: a practical introduction to structure, mechanism and data analysis (second edition). John Wiley & Sons, Inc., New York, USA.
  18. Shoop, W. L., Xiong, Y., Wiltsie, J., Woods, A., Guo, J., Pivnichny, J. V., Felcetto, T., Michael, B. F., Bansal, A., Cummings, R. T. Cunningham, B. R., Friedlander, A. M., Douglas, C. M., Patel, S. B., Wisniewski, D., Scapin, G., Salowe, S. P., Zaller, D. M., Chapman, K. T., Scolnick, E. M., Schmatz, D. M., Bartizal, K., MacCoss, M. and Hermes, J. D. (2005) Anthrax lethal factor inhibition. Proc. Natl. Acad. Sci. U.S.A. 102, 7958-7963. https://doi.org/10.1073/pnas.0502159102

Cited by

  1. Identification of Toxin Inhibitors Using a Magnetic Nanosensor-Based Assay vol.10, pp.6, 2014, https://doi.org/10.1002/smll.201301824
  2. Small-molecule probes elucidate global enzyme activity in a proteomic context vol.47, pp.3, 2014, https://doi.org/10.5483/BMBRep.2014.47.3.264
  3. A high-throughput screening assay to identify bacterial antagonists againstFusarium verticillioides vol.54, pp.S1, 2014, https://doi.org/10.1002/jobm.201200594